Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicola Ferri

Showing results (1-10 of 260) with videos related to

Pageof 26
Sort By:
Vascular Pharmacology|November 15, 2011
AMP-activated protein kinase and the control of smooth muscle cell hyperproliferation in vascular diseaseNicola Ferri
Journal of Cardiovascular Pharmacology|September 28, 2013
Pharmacological modulation of small GTPases in cardiovascular diseases: from statins to selective inhibitorsNicola Ferri
Scientifica|November 27, 2013
Proprotein convertase subtilisin/kexin type 9: from the discovery to the development of new therapies for cardiovascular diseasesNicola Ferri
JACC. Basic to Translational Science|June 25, 2025
Do Anti-PCSK9 Monoclonal Antibodies Have Pleiotropic Effects?Nicola Ferri
Ebiomedicine|March 10, 2021
Phage display for targeting PCSK9Nicola Ferri
Atherosclerosis|November 16, 2024
Statin-associated muscle symptoms: Not simply a genetic predispositionNicola Ferri, Alberto Corsini
Atherosclerosis Plus|January 13, 2025
Emerging oral therapeutic strategies for inhibiting PCSK9Nicola Ferri, Giorgia Marodin
Pharmacological Research|August 31, 2023
Mechanism of bempedoic acid induced cholelithiasis: A role for statins to limit this adverse effect?Nicola Ferri, Alberto Corsini
Current Atherosclerosis Reports|June 5, 2020
Clinical Pharmacology of Statins: an UpdateNicola Ferri, Alberto Corsini
Vascular Pharmacology|March 5, 2015
Naturally occurring PDGF receptor inhibitors with potential anti-atherosclerotic propertiesChiara Ricci, Nicola Ferri
Pageof 26

Showing results (1-10 of 260) with videos related to

Sort By:
Pageof 26
Vascular Pharmacology|November 15, 2011
AMP-activated protein kinase and the control of smooth muscle cell hyperproliferation in vascular diseaseNicola Ferri
Journal of Cardiovascular Pharmacology|September 28, 2013
Pharmacological modulation of small GTPases in cardiovascular diseases: from statins to selective inhibitorsNicola Ferri
Scientifica|November 27, 2013
Proprotein convertase subtilisin/kexin type 9: from the discovery to the development of new therapies for cardiovascular diseasesNicola Ferri
JACC. Basic to Translational Science|June 25, 2025
Do Anti-PCSK9 Monoclonal Antibodies Have Pleiotropic Effects?Nicola Ferri
Ebiomedicine|March 10, 2021
Phage display for targeting PCSK9Nicola Ferri
Atherosclerosis|November 16, 2024
Statin-associated muscle symptoms: Not simply a genetic predispositionNicola Ferri, Alberto Corsini
Atherosclerosis Plus|January 13, 2025
Emerging oral therapeutic strategies for inhibiting PCSK9Nicola Ferri, Giorgia Marodin
Pharmacological Research|August 31, 2023
Mechanism of bempedoic acid induced cholelithiasis: A role for statins to limit this adverse effect?Nicola Ferri, Alberto Corsini
Current Atherosclerosis Reports|June 5, 2020
Clinical Pharmacology of Statins: an UpdateNicola Ferri, Alberto Corsini
Vascular Pharmacology|March 5, 2015
Naturally occurring PDGF receptor inhibitors with potential anti-atherosclerotic propertiesChiara Ricci, Nicola Ferri
Pageof 26